1. Home
  2. IMVT vs TENB Comparison

IMVT vs TENB Comparison

Compare IMVT & TENB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • IMVT
  • TENB
  • Stock Information
  • Founded
  • IMVT N/A
  • TENB 2002
  • Country
  • IMVT United States
  • TENB United States
  • Employees
  • IMVT N/A
  • TENB N/A
  • Industry
  • IMVT Biotechnology: Biological Products (No Diagnostic Substances)
  • TENB Computer Software: Prepackaged Software
  • Sector
  • IMVT Health Care
  • TENB Technology
  • Exchange
  • IMVT Nasdaq
  • TENB Nasdaq
  • Market Cap
  • IMVT 4.2B
  • TENB 4.8B
  • IPO Year
  • IMVT N/A
  • TENB 2018
  • Fundamental
  • Price
  • IMVT $26.77
  • TENB $42.13
  • Analyst Decision
  • IMVT Strong Buy
  • TENB Buy
  • Analyst Count
  • IMVT 11
  • TENB 16
  • Target Price
  • IMVT $48.10
  • TENB $50.40
  • AVG Volume (30 Days)
  • IMVT 799.9K
  • TENB 788.0K
  • Earning Date
  • IMVT 02-10-2025
  • TENB 02-04-2025
  • Dividend Yield
  • IMVT N/A
  • TENB N/A
  • EPS Growth
  • IMVT N/A
  • TENB N/A
  • EPS
  • IMVT N/A
  • TENB N/A
  • Revenue
  • IMVT N/A
  • TENB $877,596,000.00
  • Revenue This Year
  • IMVT N/A
  • TENB $14.43
  • Revenue Next Year
  • IMVT N/A
  • TENB $9.64
  • P/E Ratio
  • IMVT N/A
  • TENB N/A
  • Revenue Growth
  • IMVT N/A
  • TENB 13.97
  • 52 Week Low
  • IMVT $24.61
  • TENB $35.25
  • 52 Week High
  • IMVT $45.58
  • TENB $53.50
  • Technical
  • Relative Strength Index (RSI)
  • IMVT 44.77
  • TENB 46.43
  • Support Level
  • IMVT $26.19
  • TENB $41.52
  • Resistance Level
  • IMVT $28.08
  • TENB $42.95
  • Average True Range (ATR)
  • IMVT 1.01
  • TENB 1.08
  • MACD
  • IMVT -0.03
  • TENB -0.16
  • Stochastic Oscillator
  • IMVT 32.73
  • TENB 24.52

About IMVT Immunovant Inc.

Immunovant Inc is a clinical-stage biopharmaceutical company. It is focused on enabling normal lives for patients with autoimmune diseases. The company's product includes batoclimab and IMVT-1402 targets the neonatal Fc receptor (FcRn).

About TENB Tenable Holdings Inc.

Founded in 2002, Tenable is a cybersecurity company that began providing vulnerability management solutions under its Nessus software. In recent years, Tenable has expanded its portfolio to provide a broader range of exposure management modules. Solutions include cloud security and compliance, active directory management, operational technology security and advanced vulnerability analytics. The Maryland-based company went public in 2018.

Share on Social Networks: